Clinical Trials List
2010-08-30 - 2012-09-30
Phase III
Terminated7
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Wei- Chang Huang Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
- 覃俊士 Division of Thoracic Medicine
- Ming -Cheng Chan Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
- Chieh-Liang Wu Division of Thoracic Medicine
- 沈光漢 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chun-Hua Wang Division of Thoracic Medicine
- kang-Yun LEE Division of Thoracic Medicine
- Shu-Min Lin Division of Infectious Disease
- Horng-Chyuan Lin Division of Infectious Disease
- 羅友倫 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 梁信杰 Division of Thoracic Medicine
- Yu-Chao Lin Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
624 participants
